TSXV:ARCH - Post Discussion
Post by
Viking2233 on Apr 26, 2024 9:49am
Algorithms back in control
We had a nice run over the last 6 months with the share price going from $1 to $2.56. We had lits of material news released during this time frame. We dosed our first patient for the AKI phase 2 trial and announced another trial to commence in the summer with our repurpised drug.
We now return to a silent period as we continue to dose patients across 6 Turkish locations and soon to commence in 3 Canadian sites.
We now sit and wait as the trials commence and dsta collected.
The lack of buying has settled in as the big boys wait for data to signal positive results, the downside is that this lack data provides a very quiet period and breeds ideal environment for the Algorithms to take back control and manipulate the stock based on absolutely nothing. It is hard to watch the share price eroded daily by these banksters or should I say gangsters.
We are again beliw $100M usd market cap which in itself is ridiculous when you look at the science and compare Arch to similar staged companies. We should be well above $10 at this stage but our time will come, as they say "Patience is a virtue"
Good luck to all the shareholders who are long!
Be the first to comment on this post